We are live on ! Find out more
GRTS

Gritstone bio, Inc. Common Stock
GRTS

Delisted

GRTS was delisted on the 21st of October, 2024.

Back to rankings

52 hedge funds and large institutions have $279M invested in Gritstone bio, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 16

44% more capital invested

Capital invested by funds: $194M → $279M (+$85.5M)

21% more funds holding

Funds holding: 43 → 52 (+9)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

33% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 12

Holders
52
Holders Change
+9
Holders Change %
+20.93%
% of All Funds
1.16%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
27
Increased
8
Reduced
12
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Blackstone Inc
Blackstone Inc
New York
+$49M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$23.9M
3
BlackRock
BlackRock
New York
+$7.63M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.87M
5
UBS AM
UBS AM
Illinois
+$4.11M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$4.21M
2
FCMI
Foresite Capital Management IV
California
-$2.49M
3
PC
PointState Capital
New York
-$1.85M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.61M
5
Millennium Management
Millennium Management
New York
-$1.23M
Name Holding Trade Value Shares
Change 		Change in
Stake
AF
51
Allworth Financial
California
$2K +$1.91K +100 New
TRCT
52
Tower Research Capital (TRC)
New York
$1K +$1.49K +78 New
Goldman Sachs
53
Goldman Sachs
New York
– -$4.21M -295,711 Closed
FCMI
54
Foresite Capital Management IV
California
– -$2.49M -175,000 Closed
PC
55
PointState Capital
New York
– -$1.85M -130,000 Closed
Alyeska Investment Group
56
Alyeska Investment Group
Illinois
– -$1.61M -113,300 Closed
Millennium Management
57
Millennium Management
New York
– -$1.23M -86,522 Closed
GTC
58
Ghost Tree Capital
New York
– -$1.07M -75,000 Closed
PVI
59
Pura Vida Investments
New York
– -$1.07M -75,000 Closed
MWNA
60
Marshall Wace North America
New York
– -$385K -27,045 Closed
HI
61
HBK Investments
Texas
– -$356K -25,000 Closed
DIM
62
DC Investments Management
Virginia
– -$296K -20,760 Closed
AllianceBernstein
63
AllianceBernstein
Tennessee
– -$285K -20,000 Closed
ACM
64
Asymmetry Capital Management
California
– -$285K -20,000 Closed
PCM
65
Pentwater Capital Management
Florida
– -$244K -17,100 Closed
Norges Bank
66
Norges Bank
Norway
– -$142K -10,000 Closed
Point72 Asset Management
67
Point72 Asset Management
Connecticut
– -$142K -10,000 Closed
PHK
68
Point72 Hong Kong
Hong Kong
– -$97K -6,818 Closed
1 2
3

GRTS Hedge Fund Activity: Q4 2018 in Review

52 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q4 2018, worth a combined $279M — up 44% from $194M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new GRTS positions and 16 closed out — a net gain of 11 holders — while 8 added to existing stakes and 12 trimmed.

The largest buyer was Blackstone Inc, opening a new position worth an estimated $49M. The largest seller was Goldman Sachs, exiting entirely with an estimated $4.21M sold.

  • 52 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q4 2018, up from 43 in Q3 2018.
  • Funds reported $279M of Gritstone bio, Inc. Common Stock stock for Q4 2018, up 44% quarter-over-quarter.
  • 27 funds opened new Gritstone bio, Inc. Common Stock positions in Q4 2018 and 16 closed out, a net change of +11 holders.
  • The largest Gritstone bio, Inc. Common Stock buyer in Q4 2018 was Blackstone Inc, an estimated $49M added.
  • The largest Gritstone bio, Inc. Common Stock seller in Q4 2018 was Goldman Sachs, an estimated $4.21M sold.

Based on aggregated 13F filings for Q4 2018.